Advocate Health to Launch Drone Delivery Network for Lab Specimens
The partnership with Zipline aims to reduce turnaround times for results by transporting samples between hospitals and laboratories.
The partnership with Zipline aims to reduce turnaround times for results by transporting samples between hospitals and laboratories.
Tempus has introduced Paige Predict, an AI-powered pathology suite that analyzes H&E slides to predict 123 biomarkers across 16 cancer types when tissue samples are insufficient.
High-grade serous carcinoma identified in cervical biopsies is overwhelmingly secondary to upper genital tract tumors, most commonly of endometrial origin, the study finds.
AIxMed and Lumea have partnered to integrate AIxMed’s urine cytology diagnostic tool, AIxURO, into Lumea’s digital pathology platform.
Immunohistochemistry (IHC) offers a reliable, cost-effective alternative to genetic testing for diagnosing soft tissue tumors.
Evident has launched the IXplore IX85 SpinXL and SpinSR, two advanced spinning disk confocal microscopes that enhance live-cell imaging.
Sarana Health has partnered with My One Medical Source (MOMS) to offer nationwide, streamlined access to diagnostic specimen collection.
AMSBIO has expanded its iMatrix series of recombinant laminin E8 fragments to now include laminin isoforms LN-111 and LN-332.
Scopio Labs has received its fourth FDA clearance for enhanced decision support features in its X100 and X100HT platforms.
Codex technology combines the advantages of single-cell biology with histology at single-cell spatial resolution.